Responses of human colorectal tumor cells to treatment with the anti-epidermal growth factor receptor monoclonal antibody ICR62 used alone and in combination with the EGFR tyrosine kinase inhibitor gefitinib

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)7708-7715
    JournalCancer Research
    Volume66
    Issue number15
    DOIs
    Publication statusPublished - 1 Aug 2006

    Keywords

    • Allied health professions and studies

    Cite this